Cargando…
Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use
Immunostimulatory CpG ODNs have been developed and utilized as TLR9-dependent innate immune activators and vaccine adjuvants. Four different types of immunostimulatory CpG ODNs (A/D, B/K, C, and P type) have been reported. A/D type ODNs are characterized by high IFN-α production but intrinsically fo...
Autores principales: | Aoshi, Taiki, Haseda, Yasunari, Kobiyama, Kouji, Narita, Hirotaka, Sato, Hideaki, Nankai, Hirokazu, Mochizuki, Shinichi, Sakurai, Kazuo, Katakai, Yuko, Yasutomi, Yasuhiro, Kuroda, Etsushi, Coban, Cevayir, Ishii, Ken J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562176/ https://www.ncbi.nlm.nih.gov/pubmed/26380317 http://dx.doi.org/10.1155/2015/316364 |
Ejemplares similares
-
RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine
por: Hayashi, Masayuki, et al.
Publicado: (2016) -
Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination
por: Kobiyama, Kouji, et al.
Publicado: (2013) -
The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant
por: Tang, Choon Kit, et al.
Publicado: (2013) -
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
por: Hanagata, Nobutaka
Publicado: (2012) -
Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells
por: Kitahata, Yuji, et al.
Publicado: (2016)